Fresenius Wins U.S. Appeal Over Baxter Hemodialysis Patent

Fresenius Medical Care AG won a U.S. appeals court ruling today that will end a patent-infringement claim brought against it by Baxter International Inc. (BAX) over kidney dialysis machines.

The U.S. Patent and Trademark Office has canceled the Baxter patent after a review while the civil suit was still pending, so there is no longer any basis for Baxter’s claim, the U.S. Court of Appeals for the Federal Circuit ruled in Washington today. The opinion was posted on the court’s website.

To contact the reporter on this story: Susan Decker in Washington at sdecker1@bloomberg.net

To contact the editor responsible for this story: Bernard Kohn at bkohn2@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.